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Nephritogenic cytokines and disease in MRL-Fas lpr kidneys kines are evident prior to and during kidney destruction
are dependent on multiple T-cell subsets. in MRL-Fas lpr mice. We previously established that a
Background. Renal parenchymal cells produce cytokines, macrophage (M f ) growth factor, colony-stimulating fac-colony-stimulating factor-1 (CSF-1), granulocyte-macrophage
tor-1 (CSF-1), and tumor necrosis factor-a (TNF-a) in-colony-stimulating factor (GM-CSF), and tumor necrosis fac-
tor-a (TNF-a), which recruit autoreactive T cells and, in turn, crease simultaneously in the kidney and circulation in
elicit renal injury in MRL-Fas lpr mice. MRL-Fas lpr mice [2, 3]. CSF-1 and TNF-a were detected
Methods. To determine whether select T-cell populations reg- well in advance of renal injury and increase with progres-ulate intrarenal nephritogenic cytokines (CSF-1, GM-CSF, and
sive renal damage [2, 3]. Intrarenal gene transfer of CSF-1TNF-a) and renal disease, we compared MRL-Fas lpr mice that
are genetically deficient in T-cell receptor (TCR) ab T cells, or granulocyte-macrophage colony-stimulating factor
CD4 T cells, and major histocompatibility complex class I (GM-CSF) elicited leukocyte infiltration (M f and T
(MHC class I), lacking CD8 and double negative (DN) T cells, cells) in MRL-Fas lpr kidneys [4, 5]. Only select cytokineswith wild-type mice. To identify the T cells instrumental in
individually gene transferred into the kidney incite in-downstream (effector) events, we delivered CSF-1 or GM-CSF
into the kidney via gene transfer in these select T-cell–deficient flammation. For example, intrarenal delivery of TNF-a
and wild-type strains. alone did not elicit inflammation, while dual delivery of
Results. Intrarenal CSF-1, GM-CSF, and TNF-a were absent CSF-1 along with TNF-a dramatically enhanced CSF-1or dramatically reduced in TCR ab, CD4, and class I-deficient
elicited leukocytic infiltration in MRL-Fas lpr kidneysMRL-Fas lpr strains as compared with wild-type mice. In addi-
tion, the decrease in CSF-1, GM-CSF, and TNF-a was associ- [4, 5]. These findings imply that intrarenal expression of
ated with a reduced kidney leukocytic infiltrates and spontane- CSF-1, GM-CSF, and TNF-a are nephritogenic and are
ous autoimmune nephritis. Intrarenal ex vivo retroviral gene instrumental in progressive renal disease characteristictransfer of CSF-1 and GM-CSF failed to elicit nephritis in these
of the MRL-Fas lpr strain. To identify the stimulus respon-T-cell–deficient MRL strains (TCR ab, CD4, CD8/DN) as com-
pared with wild-type mice. sible for increasing CSF-1 and TNF-a, we determined
Conclusions. Multiple T-cell populations initiate renal dis- that intrarenal CSF-1 and TNF-a and autoimmune renal
ease by increasing intrarenal nephritogenic cytokines, CSF-1, disease did not result from an intrinsic kidney defect,GM-CSF, and TNF-a. CSF-1 and GM-CSF recruit additional
but rather, were dependent on circulating componentsCD4 and CD8 and DN T cells, which augment downstream
events, resulting in progressive autoimmune renal disease. in MRL-Fas lpr mice with nephritis [6, 7]. We concluded
We suggest that MRL-Fas lpr kidney disease is driven by a that T cells were the circulating component. Consistent
T-cell amplification feedback loop dependent on multiple with this concept, intrarenal T cells secreting interferon-gT-cell populations.
(IFN-g) initiated, accelerated, and promoted the destruc-
tion of autoimmune renal disease. Our current challenge
is to identify the T-cell populations responsible for induc-Autoimmune kidney disease in MRL/MPJ-lpr/lpr
ing nephritogenic cytokines and promoting autoimmune(MRL-Fas lpr) mice is complex, involving glomerular, in-
renal disease in MRL-Fas lpr mice.terstitial, tubular, and perivascular pathology [1]. Cyto-
T cells infiltrate and accumulate in the kidneys and
are instrumental in autoimmune nephritis in MRL-Fas lprKey words: CSF-1, GM-CSF, TNF-b, macrophages, lupus nephritis,
gene transfer. mice. Intrarenal CD4 T cells, and unique double negative
(DN) T cells (CD42, CD82, B2201, CD21/352) are equallyReceived for publication June 6, 2000
abundant in progressive renal disease, while CD8 T cellsand in revised form August 21, 2000
Accepted for publication August 30, 2000 are less notable [1]. MRL-Fas lpr strains that either lacked
T-cell receptor (TCR) ab T cells, CD4 T cells, or classÓ 2001 by the International Society of Nephrology
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I-selected CD8 and DN T cells have a reduced glomeru- Chemical Co. (St. Louis, MO, USA). Polyclonal rabbit
anti-mouse L cell-derived CSF-1 and polyclonal rabbitlar pathology and autoantibodies [8–11]. However, the
consequence of these select T-cell deficiencies on the anti-human CSF-1 were provided by Dr. R. Shadduck
(Montefiore Hospital, Pittsburgh, PA, USA) and the Ge-intrarenal nephritogenic cytokines, interstitial and tu-
bular pathology, and the cytokine-dependent effector netics Institute (Cambridge, MA, USA), respectively.
Rabbit antimurine TNF-a antibody was a gift fromphase of nephritis in the MRL-Fas lpr mice has not been
investigated. Dr. A. Cerami (Picower Institute for Medical Research,
Manhasset, NY, USA) [13]. Monoclonal antibody forIn this study, we tested the hypothesis that select T-cell
populations in MRL-Fas lpr mice are required to generate F4/80 antigen (American Tissue Culture Collection,
Rockville, MD, USA) was purified by affinity chroma-intrarenal cytokines during the initiation and effector
phase of autoimmune renal disease. To achieve these tography using protein A-Sepharose CL-4B columns
(Pharmacia, Piscataway, NJ, USA). Monoclonal anti-goals, we evaluated (1) intrarenal nephritogenic cyto-
kines (CSF-1, GM-CSF, TNF-a) and spontaneous kidney bodies to CD4, CD8, B220, biotinylated antimurine
GM-CSF antibody, and fluorescence-conjugated murinepathology and (2) intrarenal gene transfer of CSF-1 or
GM-CSF–elicited nephritis in MRL-Fas lpr strains, which IgG were purchased from PharMingen (San Diego,
CA, USA).lacked ab T cells, CD4 T cells, and MHC class I-selected
CD8 and DN T cells. We now report that multiple T cells
Cytokine expressionare responsible for intrarenal CSF-1, GM-CSF, and
TNF-a and spontaneous autoimmune renal disease. Intrarenal transcripts. We evaluated intrarenal CSF-1,
TNF-a, and GM-CSF transcripts in the renal cortex byT-cell populations (TCR ab, CD4 and class I selected
CD8 and DN) are required for CSF-1 or GM-CSF– Northern blot analysis. Total RNA was extracted from
the renal cortex using RNAzol B (Tel-Test, Friends-incited renal pathology. These T-cell requirements are
not restricted to initiation, but are necessary for the wood, TX, USA), a modification of the guanidium thio-
cyanate-phenolchloroform method [14]. RNA was washeddownstream, effector phase of autoimmune renal dam-
age. We note that in the absence of these select T-cell with 70% ethanol, resuspended in diethylpyrocarbonate
(DEPC)-treated H2O and stored at 2808C. Total RNApopulations, M f remain abundant, but are not capable
of promoting progressive kidney disease. These findings (20 mg) was electrophoresed through a 1% agarose-form-
aldehyde gel, blotted to nylon membrane, and hybridizedare consistent with a T-cell amplification loop that pro-
motes intrarenal cytokine expression and progressive au- in 50% formamide with 32P-labeled nick-translated probes
at 428C. Hybridized membranes were washed in 2 3toimmune renal disease. Multiple T-cell populations con-
tribute to intrarenal nephritogenic cytokines CSF-1, standard saline citrate (SSC), 0.1% sodium dodecyl sul-
fate (SDS) at room temperature and then washed inGM-CSF, and TNF-a. In turn, these cytokines recruit
CD4, CD8, and/or DN T cells, which further augment 0.2 3 SSC, 0.1% SDS at 608C. The CSF-1, TNF-a, and
GM-CSF probes, kindly provided by Dr. R. Stanley (Al-nephritogenic cytokines and drive a cascade of events
that culminates in lethal kidney damage. bert Einstein College of Medicine, New York, NY,
USA), Dr. K. Matsushima (University of Tokyo, Tokyo,
Japan), and Dr. G. Dranoff (Dana-Faber Cancer Insti-
METHODS
tute, Boston, MA, USA), respectively, consisted of 594,
Mice 500, and 400 bp fragments of the plasmid containing the
cDNA. Blots were reprobed with b-actin (Pst-1 fragmentAutoimmune MRL-Faslpr (H-2k) and MRL-11 (H-2k)
were purchased from The Jackson Laboratory (Bar Har- of pBA-1) as an internal control to assess the RNA
quantity and integrity. The blots were analyzed by densi-bor, ME, USA). TCR ab-deficient MRL-Fas lpr mice
were derived through a series of six generations of back- tometry to quantitate mRNA.
Intrarenal proteins. We detected CSF-1, TNF-a, andcrosses as previously reported [9, 12]. Similarly, CD4-
deficient MRL-Fas lpr mice were derived through a series GM-CSF in kidney sections using polyclonal rabbit anti-
human CSF-1 antibody (10 mg/mL), rabbit anti-murineof seven to eight generations of backcrosses [11]. The b2-
microglobulin (b2m), MHC class I, deficient MRL-Fas lpr TNF-a antibody (1:150 dilution), and biotinylated rat
antimurine GM-CSF antibody (50 mg/mL) using the im-mice at the 10th backcross generation were purchased
from Jackson Laboratory [10]. Mice were maintained in munoperoxidase technique [3, 15]. Tissue sections were
incubated with CSF-1, TNF-a, and GM-CSF antibodiesour animal facility on standard laboratory chow.
in 1% bovine serum albumin (BSA) overnight at 48C.
Reagents Specificity controls included (1) replacing the primary
antibody with either normal rat IgG or rabbit serumTissue culture media and supplements were purchased
from GIBCO/BRL Life Technologies (Grand Island, and (2) antibody neutralization by incubating antimurine
CSF-1, TNF-a, and GM-CSF antibodies with a 20-foldNY, USA), and chemicals were purchased from Sigma
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molar excess of recombinant murine CSF-1, TNF-a, and 2 5 100 to 300 mg/dL, 3 5 300 to 1000 mg/dL, 4 5 .1000
mg/dL; Albustix; Miles Scientific, Naperville, IL, USA),GM-CSF, respectively (R&D Systems, Minneapolis, MN,
as shown in Table 1.USA). We evaluated .50 glomeruli and .20 intersti-
Deposition of IgG. Semiquantitative evaluation of thetium/perivascular areas containing .400 tubules per kid-
glomerular deposition of mouse IgG was performed byney in randomly selected microscopic fields (magnifica-
direct immunofluorescence staining using a semiquanti-tion 3400). The numbers of cells expressing CSF-1,
tative grading system ranging from 0 to 3 (0 5 none,TNF-a, and GM-CSF were graded on a scale from 0 to 3
1 5 mild, 2 5 moderate, 3 5 severe), as shown in Table 1.(0, 0 cells per field; 1, mild 5 ,10 cells per field; 2,
Identifying kidney infiltrating leukocyte phenotypes. Tomoderate 5 10 to 100 cells per field; 3, maximum 5 .100
evaluate the leukocytic phenotypes that infiltrate intocells per field) and determined the mean grade as shown
the kidney, we identified M f , CD4, CD8, and DN Tin Figure 1. Scoring was performed on coded slides.
cells. Cryostat-sectioned kidneys were stained for the
Renal disease presence of M f and T cells (CD4, CD8, DN) with mono-
clonal antibodies using the avidin-biotin complex immu-Renal pathology. We examined kidneys from wild-
noperoxidase technique [15]. The intrarenal M f and Ttype MRL-Faslpr mice, T-cell–deficient MRL-Faslpr strains,
cells (CD4, CD8, and DN) were enumerated both inand MRL-11 mice at three and six months of age. Kid-
glomeruli (within glomeruli and adjacent to glomeruli)ney sections evaluated by histopathology were fixed with
and interstitium (adjacent to cortical tubules and perivas-10% buffered formalin and then paraffin embedded and
cular areas) in 20 randomly selected microscopic fieldsstained with hematoxylin and eosin. Coded slides were
(magnification 3400). The intrarenal M f and T cellsanalyzed by two individuals. The entire renal pathology
were graded on a scale from 0 to 3 (0 5 none; 1 5 mild,(consisting of glomerulonephritis, interstitial/perivascu-
,50 per field; 2 5 moderate, 50 to 100 per field; 3 5lar nephritis and tubular damage) was evaluated using
severe, .100 per field), and the mean grade per fielda grading system ranging from 0 to 3: 0 5 none, 1 5
was determined (Fig. 6). T-cell intrarenal phenotypesmild, 2 5 moderate, and 3 5 severe to generate data in
CD4, CD8, and DN T cells were graded on a scale fromFigure 4. The extent of renal pathology was assessed by
0 to 3 (0 5 none; 1 5 mild, ,10 per field; 2 5 moderate,determining (1) the percentage of crescents (defined as
10 to 50 per field; 3 5 severe, .50 per field), and thethickening of Bowman’s capsule wall with 2 or more cell
mean grade per field was determined (Fig. 7). Scoring
layers); (2) the percentage of segmental lesions (exhib-
was performed on coded slides by two blinded observers.
iting at least one of the following: necrosis, proliferation,
hyalinosis) in glomeruli; (3) the percentage of damaged Ex vivo gene transfer system delivering M f growth
tubuli (consisting of at least one of the following: dilata- factor “carrier cells” into the kidneys
tion, atrophy, necrosis) in randomly selected microscopic We delivered CSF-1 and GM-CSF into the kidney using
fields (magnification 3400) to generate data in Table 1. an ex vivo gene transfer system. TEC from MRL-Fas lpr
We determined the cell number in the glomeruli, intersti- mice at one to two months of age was isolated and these
tial, and vascular areas to generate Figure 5. Specifically, TEC infected with recombinant retroviruses encoding
we counted cells in the intraglomerular (glomerular resi- CSF-1 and GM-CSF as previously described [4, 16–19].
dent cells, leukocytic infiltrates, and cells in crescents To ensure that genetically modified TEC, termed CSF-1
within Bowman’s capsule) and periglomerular areas or GM-CSF “carrier cells,” produced these M f growth
(outside Bowman’s capsule) of 50 randomly selected glo- factors, the release of CSF-1 or GM-CSF was measured
meruli and evaluated the mean enumerated cells per in these culture supernatants, respectively [20]. The via-
glomerulus (Fig. 5A, B). Kidney leukocytic infiltrates bility of TEC immediately before implantation was
within the cortical interstitium were counted in 20 ran- .90% assessed by trypan blue staining. We implanted
domly selected fields of cortical interstitium and mean CSF-1 or GM-CSF “carrier cells” or uninfected TEC
cells per field calculated (Fig. 5C). The perivascular leu- (1 3 106 TEC in 50 mL of HBSS) under the left renal
kocytic cells were evaluated in 20 interlobular and intra- capsule of recipient mice at two to three months of age
lobular arteries and graded by counting the number of [4]. At 14 or 28 days postimplant, the kidney implanted
cell layers surrounding each vessel: 0 5 none; 1 5 ,5 with CSF-1 or GM-CSF “carrier cells” was excised, and
layers surrounding ,50% of the vessel; 2 5 5 to 10 layers the accumulation of cells in the subcapsular implant site
surrounding .50% of the vessel; 3 5 .10 layers. Finally, and adjacent renal cortex was assessed by enumerating
the mean grade was determined (Fig. 5D). the maximum number of cell layers within these areas
Proteinuria. Urine protein levels in T-cell–deficient as shown in Figures 8 and 9-1. The percentage of M f ,
MRL-Fas lpr mice were assessed semiquantitatively using CD4, CD8, and DN T cells were expressed as an index
[maximal subcapsular cell layers 3 leukocytic pheno-albumin reagent strips (0 5 none, 1 5 30 to 100 mg/dL,
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types (%)] as in Figure 9-2. To determine that CSF-1 sex-matched wild-type mice mostly within TEC and glo-
meruli in T-cell–depleted strains (Figs. 1B and 3F, G, H).and GM-CSF “carrier cells” produce CSF-1 or GM-CSF,
In contrast to CSF-1 and TNF-a, which are evidentkidneys were stained for the presence of either cytokine
prior to renal disease (1 to 2 months of age), no GM-CSFusing the immunoperoxidase technique [15].
in MRL-Fas lpr kidneys was detected at one and twoCirculating proteins. To evaluate the amount of circu-
months of age (data not shown). However, intrarenallating cytokines, recipient mice were bled 7 days prior
GM-CSF expression did increase during renal diseaseto implanting CSF-1 or GM-CSF “carrier cells” and at
in MRL-Fas lpr mice (Figs 1C, 2C, 3I, J). Thus, an up-14 and 28 days follow this procedure. Biologically active
regulation of intrarenal GM-CSF is downstream fromCSF-1 and GM-CSF in TEC supernatants and serum sam-
CSF-1 and TNF-a. By comparison, TCR ab, CD4, andples were measured using the colony-stimulating assay
b2m-deficient MRL-Fas lpr strains at three and six months(CSA) [20], as shown in Table 2.
of age did not express GM-CSF (Figs. 1C and 2C).
Statistical analysis Circulating proteins. The pattern of cytokine produc-
tion in the kidneys closely paralleled the cytokine pro-The data represent the means 6 SEM. Statistical signifi-
duction profile in the circulation. Specifically, CSF-1 wascance was determined by analysis of variance (ANOVA).
absent from the sera of MRL-Fas lpr strains deficient in
TCR ab and CD4 at six months of age [4 6 5 and 2 6
RESULTS 1 colony-forming unit (CFU)], respectively, compared
with the wild-type strain (49 6 5 CFU, P , 0.01, N 5Multiple T-cell populations are required for CSF-1,
3 to 4 per group). Similarly, CSF-1 was diminished inTNF-a, and GM-CSF in MRL-Faslpr mice
b2m-deficient MRL-Fas lpr mice (10 6 1 CFU) comparedIntrarenal transcripts and proteins. We analyzed CSF-1,
with the wild-type strain (49 6 5 CFU, P , 0.01, N 5TNF-a, and GM-CSF expression in the kidney of MRL-
3 per group).Fas lpr strains deficient in TCR ab, CD4, or b2m using
immunostaining (Figs. 1 and 3) and Northern blot analy- Reduced renal diseases in T-cell–deficient
sis (Fig. 2). CSF-1, TNF-a, and GM-CSF were up-regu- MRL-Faslpr strains
lated between three and six month of age in wild-type
T cells play an important role in long-term spontaneous
MRL-Faslpr kidney as compared with normal kidneys from
renal injury in MRL-Fas lpr mice. To determine the im-
age matched MRL-11 mice (Fig. 1). We localized CSF-1
pact of select T-cell populations on spontaneous autoim-
(Figs. 1A and 3A), TNF-a (Figs. 1B and 3E), and GM- mune renal injury in MRL-Fas lpr mice, we evaluated the
CSF (Figs. 1C and 3I, J) within glomeruli, the intersti- extent of renal pathology in MRL-Fas lpr strains deficient
tium, TEC, and perivascular areas and within kidney infil- in TCR ab, CD4, or b2m in comparison to wild-typetrating leukocytes. In contrast, we did not detect CSF-1 MRL-Fas lpr mice and MRL-11 mice at six months of
in TCR ab-deficient MRL-Fas lpr or CD4-deficient MRL- age (Figs. 4 and 5, and Table 1). We selected this age
Fas lpr mouse kidneys at three and six months of age using point since MRL-Fas lpr mice have advanced renal pathol-
Northern blot analysis (Fig. 2A) and immunoperoxidase ogy and MRL-11 kidneys remain normal. Renal pathol-
techniques (Fig. 1A and 3B, C). Although CSF-1 was ogy in the wild-type MRL-Fas lpr strain consisted of severe
detected in glomeruli, TEC, and kidney-infiltrating leu- proliferative glomerulonephritis, interstitial/perivascular
kocytes in b2m-deficient MRL-Fas lpr mice, the level was nephritis, and tubular damage. Renal pathology was de-
far less than in the wild-type strain (Fig. 1A and 3D). creased in T-cell–deficient MRL-Fas lpr mice in compari-
The CSF-1 transcript/b-actin densitometry ratios were son to the wild-type counterparts, but remained higher
1.1 in the wild-type strain, 0.4 in TCR ab-deficient and than MRL-11 mice (Figs. 4-1, 4-2, and 5). We noted
CD4-deficient MRL-Fas lpr mice and 0.7 in b2m-deficient reductions in glomerular crescents and segmental le-
MRL-Fas lpr mice (Fig. 2). The TNF-a/b-actin densitome- sions, tubular damage (Table 1), and the numbers of
try ratios were 1.0 in the wild-type strain, 0.8 in the TCR glomerular, interstitial, and perivascular cells (Fig. 5).
ab-deficient and CD4-deficient MRL-Fas lpr mice, and The numbers of cells in the kidney were counted in four
0.9 in the b2m-deficient MRL-Fas lpr mice. The GM-CSF/ separate areas: intraglomerular, periglomerular, intersti-
b-actin densitometry ratios were 0.4 in the wild-type tial, and perivascular. There were fewer kidney cells in
strain and 0.2 in the TCR ab-deficient, CD4-deficient, the glomerular, interstitial, and perivascular areas in
and b2m-deficient MRL-Fas lpr mice. MRL-Fas lpr strains deficient in TCR ab, CD4, or b2m
Intrarenal TNF-a in MRL-Fas lpr mice is primarily ex- compared with the wild-type strain (Fig. 5). However,
pressed by TEC. The level of TNF-a in TCR a/b, CD4, the number of cells in the kidney was not reduced to
and b2m-deficient MRL-Fas lpr mice was substantially re- normal values; there were more cells in the kidney of
duced as compared with wild-type mice (Figs. 1–3). We T-cell–deficient strains than in MRL-11 mice (Fig. 5).
For example, interstitial cells decreased substantiallylocalized the TNF-a reduction in comparison to age- and
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Fig. 1. T-cell receptor (TCR) ab, CD4, and
class I-selected double negative (DN) and
CD8 T cells are required for intrarenal colony
stimulating factor-1 (CSF-1), tumor necrosis
factor-a (TNF-a), and granulocyte-macrophage
colony-stimulating factor (GM-CSF). CSF-1
and GM-CSF were not detected in MRL-Fas lpr
strains deficient in TCR ab or CD4. CSF-1
was reduced and GM-CSF was absent in b2m-
deficient MRL-Fas lpr kidneys. In comparison,
the amount of TNF-a was reduced in MRL-
Fas lpr strains deficient in TCR ab, CD4, or
b2m. N 5 2 to 4 per group at three and six
months of age. Values are mean 6 SEM.
*MRL-Fas lpr mice versus MRL-11 and T-cell–
deficient strains, P , 0.05; 1b2m-deficient
MRL-Fas lpr mice vs. MRL-11, TCR ab-defi-
cient MRL-Fas lpr, CD4-deficient MRL-Fas lpr
mice.
(59.3, 62.5, and 53.1%) in the TCR ab-deficient strain, Mf alone is not sufficient to induce autoimmune renal
CD4-deficient strain, and the b2m-deficient strain, re- injury in MRL-Faslpr mice
spectively, as compared with wild-type mice (Fig. 5). Long-term spontaneous autoimmune renal injury in
However, the decrease in the kidney cells in these MRL-Fas lpr mice. The number of kidney leukocytic
T-cell–deficient strains was not reduced to the baseline infiltrates in the kidneys of wild-type MRL-Fas lpr mice,
levels of the MRL-11 normal kidney (Figs. 4 and 5).
MRL-11 mice, and MRL-Fas lpr strains deficient in TCRSimilarly, the T-cell–deficient MRL-Fas lpr strains had less
ab, CD4, or b2m was evaluated at six months of age.proteinuria and glomerular IgG deposits as compared
The b2m-deficient (class I) mice cannot select CD8 orwith wild-type mice (Table 1). Again, the extent of pro-
DN T cells (Figs. 6 and 7) [9, 21, 22]. It is notable thatteinuria and glomerular IgG deposits remained higher
the number of M f was barely reduced in T-cell–deficientthan in the MRL-11 strains. The decrease in autoim-
MRL-Fas lpr strains as compared with the wild-typemune kidney disease was greater in the TCR ab and
(Fig. 6A). In fact, the numbers of M f were far morethe CD4 MRL-Fas lpr strains as compared with the b2m-
deficient MRL-Fas lpr mice (Table 1). abundant in the T-cell–deficient MRL-Fas lpr strains as
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Multiple T-cell populations are essential in M f
growth factor “carrier cells” elicited autoimmune
renal injury in MRL-Faslpr mice
To evaluate the impact of selective T-cell deletion on
the downstream events (effector phase), we implanted
CSF-1 and GM-CSF “carrier cells” into the kidneys using
an ex vivo gene transfer approach. As previously estab-
lished, CSF-1 or GM-CSF “carrier cells,” infused under
the renal capsule, incited a substantial accumulation of
leukocytes in the implant site in MRL-Fas lpr recipients
as compared with control “carrier cells” (Figs. 8, 9-1, and
10A) [4]. The MRL-11 strain was resistant to GM-CSF
elicited renal injury (Figs. 8 and 9-1). CSF-1 “carrier cells”
did not induce intrarenal injury in CD4-deficient MRL-
Fas lpr mice (10 6 3 cell layers per intrarenal and 22 6
3 per subcapsule) as compared with the wild-type strain
(48 6 8 per intrarenal and 40 6 10 per subcapsule, day
28 postimplant, P , 0.05). Similarly, GM-CSF “carrier
cells” did not incite intrarenal injury in TCR ab and
CD4 T-cell–deficient MRL-Fas lpr mice as compared with
the wild-type strain (Fig. 8, 9-1, and 10 B, C). GM-CSF
Fig. 2. CSF-1, TNF-a, and GM-CSF transcripts are reduced in T-cell– “carrier cells” elicited a modest intrarenal injury in b2m-
depleted MRL-Fas lpr mice. Total kidney cortex RNA from MRL-Faslpr deficient MRL-Fas lpr mice, which was dramatically lessmice (lane 1), TCR ab-deficient MRL-Fas lpr (lane 2), CD4-deficient
than in wild-type strain (Figs. 8, 9-1, and 10D). Thus, renalMRL-Fas lpr (lane 3), and b2m-deficient MRL-Faslpr mice (lane 4) at six
months of age, CSF-1 (A), TNF-a (B), GM-CSF (C ), and b-actin (D), pathology was not readily elicited by CSF-1 or GM-CSF
respectively. N 5 3 to 6 per lane. Data are representative of three in TCR ab, CD4, and b2m-deficient MRL-Faslpr strains.experiments.
To document that genetically modified TEC implanted
under the renal capsule produced M f growth factors
locally and systematically, we evaluated the circulating
cytokines using a bioassay (CSA) and probed for cyto-compared with the normal MRL-11 kidneys (Fig. 6A).
kines in the implant site by immunostaining. SerumCD4 T cells were, as anticipated, absent from the kidneys
CSF-1 was elevated in the CD4-deficient (11 6 1 CFU)of MRL-Fas lpr mice that were deficient in CD4 and TCR
and wild-type (12 6 1 CFU) at 14 days postimplant.ab (Fig. 7A). However, CD4 T cells were greatly reduced
Similarly, we detected serum GM-CSF after implanting(.50%) in b2m-deficient MRL-Fas lpr kidney (Fig. 7A).
GM-CSF “carrier cells” (Table 2). In addition, CSF-1Since class I selects for CD8 and DN T cells while class II
and GM-CSF were detected in CSF-1 and GM-CSF “car-selects for CD4 T cells, we anticipated a dramatic de-
rier cells,” respectively, by immunostaining and re-crease in CD8/DN T cells in the class I-deficient MRL-
mained in the subcapsule throughout the experimentalFas lpr strain [22]. Similarly, CD8 T cells were, as expected,
period (day 28 postimplant, data not shown). In contrast,absent in MRL-Fas lpr deficient in TCR ab or b2m and CSF-1 and GM-CSF were not detected in kidneys im-were substantially reduced (50%) in the CD4-deficient
planted with uninfected TEC (data not shown). Thus,
MRL-Fas lpr kidneys (Fig. 7B). DN T cells were absent
using a gene transfer approach, M f growth factors were
from the kidney in the b2m-deficient MRL-Fas lpr strain delivered into the kidney and circulation throughout ex-
and were greatly diminished in the TCR ab-deficient perimental period.
MRL-Fas lpr strain (Fig. 7C). This suggests that the major- We analyzed the phenotype of the leukocytic infil-
ity of intrarenal DN T cells bear TCR a/b. Interestingly, trates under the renal capsule in the GM-CSF–implanted
DN T cells were also diminished (.50%) in CD4-deficient kidneys in T-cell–deficient MRL-Fas lpr mice. We previ-
MRL-Faslpr mice compared with the wild-type strain ously noted that GM-CSF “carrier cells” elicited an ini-
(Fig. 7C). Taken together, this indicates an interdepen- tial accumulation of primarily M f (3 to 7 days), followed
dency of CD4 and CD8/DN T-cell populations in MRL- by an influx of T cells (14 to 28 days postimplant) in the
Fas lpr kidney disease. In addition, our data indicate that MRL-Fas lpr kidney [4]. The majority (80%) of the kidney
even in the presence of an abundance of M f , T-cell leukocytic infiltrates were CD4 or DN, and only a few
populations play an important role in promoting kidney Mf (10%) were detected (28 days postimplant; Fig. 9-2).
In contrast, the kidney leukocytic infiltrates in MRL-pathology.
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Fig. 3. Multiple T-cell populations are re-
quired for promoting the intrarenal production
of CSF-1, TNF-a, and GM-CSF of MRL-Fas lpr
mice. CSF-1 was detected in glomeruli (arrow-
heads), interstitium, and infiltrating cells in
MRL-Fas lpr mice at six months of age (A).
CSF-1 was not detected in MRL-Fas lpr strains
deficient in TCR ab, or CD4 (B and C ). CSF-1
was detected in the kidney of b2m-deficient
MRL-Fas lpr mice, but was less intense (D; ar-
rowheads in a glomerulus). TNF-a was strongly
detected in TEC (arrows) and glomeruli (ar-
rowheads) in MRL-Fas lpr mice at six months
of age (E ). TNF-a was reduced in MRL-Fas lpr
strains deficient in TCR ab, CD4, or b2m
(F–H; arrows in TEC). GM-CSF was detected
in glomeruli (I; arrowheads) and interstitial
infiltrating leukocytes (J; arrows) in MRL-
Fas lpr mice at six months of age, but was absent
in MRL-Fas lpr strains deficient in TCR ab, CD4,
or b2m. G, glomeruli (immunoperoxidase stain-
ing, A–D 3500; E–J 31000).
Faslpr mice that lacked select T-cell populations were pri- implanted into CD4-deficient and intact MRL-Fas lpr re-
cipients at different ages. We selected an age range dur-marily Mf (Fig. 9-2A); T cells were notably absent (Fig.
9-2B, C, D). In fact, there was an increase in the absolute ing mild, moderate, and severe renal pathologies (3, 5,
and 7 months of age, respectively) in MRL-Fas lpr mice.number of Mf in the T-cell–deficient strains compared
with the wild-type MRL-Faslpr mice, suggesting that T cells GM-CSF elicited a similar amount of kidney infiltrating
cells in MRL-Fas lpr mice at three, five, and seven monthsrelease molecules that prevent M f accumulation.
of age (20 6 8, 20 6 1, 21 6 7 cell layers, respectively,
Age did not affect M f growth factor elicited, N 5 2 to 4 per point). In contrast, GM-CSF “carrier
T-cell–dependent nephritis cells” did not elicit an intrarenal accumulation of kidney
infiltrating cells in age-matched CD4-deficient MRL-To evaluate the influence of age on the intrarenal
leukocytic accumulation, GM-CSF “carrier cells” were Fas lpr mice (3 6 2, 4 6 1, and 2 6 1 cell layers, respec-
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quired for the downstream events following cytokine
(CSF-1, GM-CSF)-elicited renal pathology. We also note
that these select T-cell populations reduce the intrarenal
Mf accumulation in response to M f growth factors.
However, despite an abundance of M f , these select
T-cell populations play an important role in autoimmune
nephritis. We conclude that multiple T-cell populations
are required to promote intrarenal cytokines, which in
turn recruit additional T cells that foster a feedback
amplification loop culminating in lethal autoimmune de-
struction in MRL-Fas lpr kidneys.
We report a novel finding that TCR ab, CD4, and CD8
and/or DN T cells in MRL-Fas lpr mice each contribute to
the pathologic expression of intrarenal cytokines respon-
sible for autoimmune renal disease. This finding implies
that TCR ab, CD4, and CD8 and/or DN T cells either
secrete or induce the production of these cytokines by
renal parenchymal cells. Although CD4 T cells are capa-
ble of secreting CSF-1 [23], the majority of CSF-1 in the
kidney is produced by mesangial cells [24]. Thus, we
suggest that T cells release a cytokine that induces CSF-1
production by mesangial cells. Based on our recent study,
IFN-g receptor-deficient MRL-Fas lpr mice fail to express
intrarenal CSF-1 and TNF-a and are spared from auto-
immune kidney destruction [25]. More recently, we de-
termined that IL-12 elicited autoimmune injury by fos-
tering the accumulation of IFN-g–secreting T cells and
nephritis in MRL-Fas lpr mice [26]. Therefore, we propose
that multiple intrarenal T-cell populations dependent on
IL-12 releasing IFN-g are responsible for the inducing
CSF-1 and TNF-a. Of note, CD8 and DN T cells in MRL-
Fas lpr mice secrete more IFN-g than CD4 T cells [27].
Fig. 4. TCR ab, CD4, and class I-selected DN and CD8 T cells are Therefore, we might predict that the CD8 and/or DN T
required for spontaneous kidney disease in MRL-Fas lpr mice. (1) Renal cells in the CD4-deficient MRL-Fas lpr strain would cause
pathology was decreased in T-cell–deficient MRL-Fas lpr mice, but re-
renal damage. However, few CD8 and/or DN T cellsmained elevated as compared with MRL-11 mice. (2) Glomerulone-
phritis in MRL-Fas lpr mice at six months of age (A). In contrast, renal infiltrate the kidney in the CD4-deficient MRL-Fas lpr
pathology was reduced in TCR ab-deficient MRL-Fas lpr (B) in CD4- strain; consequently, there may be insufficient IFN-g re-
deficient MRL-Fas lpr (C ) and in b2m-deficient MRL-Fas lpr (D) mice
leased locally to induce CSF-1 and TNF-a. We suggest(hematoxylin eosin, 3500).
that IFN-g delivered by kidney infiltrating TCR ab,
CD4, and CD8 and/or DN T cells may be the stimulus
that triggers the production of CSF-1 and a cascade of
tively, N 5 2 to 4 per point). Thus, M f growth factor events resulting in fatal autoimmune kidney disease.
elicited nephritis is dependent on multiple T-cell popula- Understanding the mechanism responsible for the
tions in MRL-Fas lpr mice within a broad age range during expression of TNF-a in the kidney is complex. We pre-
progressive renal disease. viously identified two distinct mechanisms of TNF-a reg-
ulation in the kidneys of MRL-Fas lpr mice. One mecha-
nism involves neonatal up-regulation of TNF-a that is
DISCUSSION related to the Fas lpr mutation; the other mechanism in-
In this report, we have tested the role of select T-cell volves an increase in TNF-a in mature mice that is pro-
populations in intrarenal cytokine expression and auto- portional to the severity of lupus nephritis [3]. This up-
immune renal injury in MRL-Fas lpr mice. We now report regulation of TNF-a prior to and during nephritis in
that TCR ab, CD4, and CD8 and/or DN T cells (1) MRL-Fas lpr mice is largely generated by TEC. This is
contribute to the intrarenal induction of nephritogenic consistent with the present study; intrarenal TNF-a was
cytokines (CSF-1, GM-CSF, and TNF-a) and autoim- diminished, but not totally absent in TCR ab, CD4,
or CD8 and/or DN T-cell–deficient MRL-Fas lpr strainsmune renal disease in MRL-Fas lpr mice, and (2) are re-
Wada et al: T cells regulating cytokines and nephritis 573
Fig. 5. TCR ab, CD4, and class I-selected CD8 and DN T cells contribute to spontaneous renal disease in MRL-Fas lpr mice. T-cell–deficient
MRL-Fas lpr strains had fewer cells in the kidney within the intraglomerular (A), periglomerular (B), interstitial (C ), and perivascular (D) areas
than in the corresponding areas in MRL-Fas lpr kidneys, but more than in the MRL-11 kidneys. Values are mean 6 SEM; N 5 3 to 5 per group
at six months of age.
Table 1. T cell-deficient MRL strains were protected from kidney injury (proteinuria, IgG deposition and renal pathology)
IF Pathology %
IgG/Glom Glom Glom Tubules
Recipient Segmental
(Strain) Proteinuria Crescent lesions Damage
MRL-Faslpr 3.760.3 2.860.2 43.765.8 96.061.5 42.665.0
TCRab-/-MRL-Faslpr 0.660.3a,d 0.660.3a,d 1.060.5b,d 11.860.8b,d 0.760.6b,d
CD4-/-MRL-Faslpr 0.660.3a,d 0.560.3a,d 1.060.5b,d 10.760.6b,d 0.860.6b,d
b2-/-MRL-Faslpr 1.360.3a,c,d 1.460.3a,c,d 2.560.5b,c,d 22.067.0b,c,d 4.560.5b,c,d
MRL-11 0.360.1 0.360.1 060 060 0.360.1
Mice were 6 months of age. N 5 3–5/group. Values are mean 6 SEM.
Abbreviations are: IF, immunofluorescence; Glom, glomerulus.
a P , 0.05, b P , 0.01, MRL-Faslpr mice vs. other T cell deficient strain
c P , 0.05, b2m deficient MRL-Faslpr mice vs. TCRab or CD4 deficient MRL-Faslpr mice
d P , 0.05, MRL-11 mice vs. T cell deficient MRL-Faslpr mice
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Fig. 6. MRL-Fas lpr strains deficient in TCR ab, CD4, or b2m have a reduction in intrarenal T cells, but Mf remain. Mf (A) and T cells (CD4,
CD8, and DN; B) were abundant in the kidney of MRL-Fas lpr mice. The intrarenal Mf were minimally reduced in strains deficient in TCR ab,
CD4, and b2m (CD8 and/or DN T cells) as compared with the T-cell populations. Although T cells were reduced, they were elevated as compared
to MRL-11 normal kidneys (B). Values 5 mean 6 SEM. N 5 3 to 5 per group at six months of age.
Fig. 7. A deficiency in several select T-cell populations in MRL-Fas lpr mice leads to a reduction in the entire intrarenal T-cell populations. TCR
ab- and CD4-deficient MRL-Fas lpr mice were spared from an intrarenal influx of CD4, CD8, and most DN T cells. b2m-deficient MRL-Fas lpr mice
were spared from an intrarenal influx of DN and CD8 T cells and most CD4 T cells. Values are mean 6 SEM; N 5 3 to 5 per group at six months
of age.
protected from progressive renal disease. Thus, multiple populations responding to TNF-a may initiate kidney
disease and subsequently stimulate the kidney to gener-T-cell populations release cytokines that induce intrare-
nal TNF-a. It is tempting to speculate that the neonatal ate more TNF-a with advancing renal disease.
We now report that intrarenal GM-CSF expression isexpression of TNF-a is a very proximal step in the devel-
opment of nephritis; multiple, interdependent T-cell downstream of CSF-1 and TNF-a expression, which ap-
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[33–35]. In addition, newly identified CC chemokines
may be involved in the trafficking and homing of select
lymphocyte subsets into specific organs [36, 37]. It is
alternatively possible that the cytokines and other mole-
cules that are responsible for intrarenal T-cell adherence
and proliferation fail to be released in the absence of
these select T-cell populations. We are currently explor-
ing the molecular interdependency of CD4, CD8, and
DN T cells in the kidney.
Our studies support the concept that an influx of M f
alone into the kidney without T cells fails to promote
autoimmune kidney disease. A dynamic interaction of
Mf and T cells is required for nephritogenic cytokines
and autoimmune renal injury in MRL-Fas lpr mice. This
is based on the finding that T-cell–deficient strains were
spared from spontaneous lethal renal injury despite an
Fig. 8. Mf growth factor “carrier cells” do not incite an intrarenal appreciable intrarenal reduction in M f . This is consistent
leukocytic infiltrates in MRL-Fas lpr strains deficient in TCR ab, CD4, with our previous finding that CSF-1 and GM-CSF “car-
or b2m. Mf growth factor “carrier cells” did not incite an intrarenal rier cells” implanted under the renal capsule recruit M faccumulation of leukocytic infiltrates in the MRL-Fas lpr strains deficient
in TCR ab, CD4, and b2m as compared with the wild-type strain. Values into normal (C3H-Hej) kidneys, but in the absence of
are mean 6 SEM; N 5 3 to 5 per group. Recipients were two to three autoreactive T cells, CSF-1 and GM-CSF do not elicit
months of age.
kidney injury [4]. In addition, M f growth factors elicited
more Mf in the kidneys of T-cell–deficient MRL-Fas lpr
mice compared with wild-type MRL-Fas lpr mice. This
finding suggests that kidney infiltrating T cells reducepear in advance of renal injury. We did not detect GM-
CSF in the T-cell–deficient MRL-Fas lpr strains. GM-CSF the accumulation of M f in the kidney. This is keeping
with our findings that IFN-g produced by kidney infil-is up-regulated by cytokines, including TNF-a and IL-1
[28–31], and is secreted by CD4 T cells [28, 29] and cyto- trating T cells is responsible for halting M f proliferation
and enhancing apoptosis of M f [38]. Thus, it is plausiblekine-stimulated glomerular epithelial cells [31]. Since
IL-1 and TNF-a are increased in proportion to the sever- that IFN-g released by T cells provides a negative regula-
tory pathway restricting M f proliferation.ity of kidney disease in MRL-Fas lpr kidneys [3, 32], it is
possible that intrarenal GM-CSF is triggered by IL-1 and We now report that b2m-deficient MRL-Fas lpr mice
deficient in CD8 and DN T cells are necessary in theTNF-a [28–31]. We suggest that GM-CSF recruits Mf
and T cells and assists in amplifying established renal initiation and effector phase of autoimmune kidney dis-
ease. Our conclusion differs with a prior study claimingdisease [4].
We have uncovered an important interplay between that the requirement for class 1 proteins is restricted
temporally to later stages of the disease [10]. This con-T-cell populations responsible for initiating and promot-
ing autoimmune kidney disease. We now report in CD4- cept is based on similar increasing levels of total immuno-
globulins in b2m-deficient MRL-Fas lpr and wild-type micedeficient MRL-Fas lpr mice that far fewer CD8 and DN
T cells are detected in the kidney, even though they in the early phase (,75 days) and heightened increases
in the wild-type as compared with the class I-deficientare abundant in the lymph nodes or circulation [11].
Similarly, b2m-deficient MRL-Fas lpr mice lacking CD8 mice during the later phase. Since CSF-1, GM-CSF, and
TNF-a remained at baseline or diminished levels at threeand DN T cells have a few intrarenal CD4 cells, de-
spite the availability of CD4 T cells in other tissues [10]. months of age and extended through six months of age,
we suggest that class I is required throughout disease inThis interdependency of T-cell populations is even more
striking in the downstream M f growth factor-initiated MRL-Fas lpr mice.
These studies further support the concept that CD8-studies. There are several possibilities. CD4 may induce
chemokines that are required to attract CD8 and DN derived DN T cells are instrumental in autoimmune ne-
phritis in MRL-Fas lpr mice. It is difficult to determineT cells, and vise versa, CD8 and DN T cells may induce
chemokines that recruit CD4 cells into the kidney. In this the impact of CD8 T cells apart from DN T cells in the
Fas lpr strains. The unique DN T cells in the Fas lpr strainsregard, we determined that monocyte chemoattractant
protein-1 (MCP-1) and regulated upon activation, nor- are derived from the CD8 lineage; thus, the CD8 “knock-
out” MRL-Fas lpr lack CD8 and DN T cells [39]. To deter-mal T cell expressed and secreted (RANTES) are de-
tected prior to and during renal injury and are required mine the impact of the DN T cells on autoimmune kidney
disease, we propagated DN T cells from MRL-Fas lpr ne-for autoimmune kidney diseases in MRL-Fas lpr mice
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Fig. 9. GM-CSF “carrier cells” elicit an enhanced M f accumulation in the renal capsule in T cell deficient MRL-Fas lpr strains. (1) GM-CSF
“carrier cells” caused less renal pathology (50%) in the TCR ab, CD4, and b2m-deficient MRL-Fas lpr strains as compared with the wild-type strain.
(2) The majority of kidney leukocytic infiltrates elicited by GM-CSF “carrier cells” in wild-type mice were CD4 and DN T cells (A–D). In contrast,
the majority of kidney leukocytic infiltrates in T-cell–deficient MRL-Fas lpr strains were Mf (A). There were more Mf in the T-cell–deficient MRL-
Fas lpr strains than in the wild-type strain (A). Values are mean 6 SEM. Recipients were two to three months of age (N 5 3 to 5 per group). Index 5
maximum cell layers 3 cell phenotypes (%).
Fig. 10. GM-CSF “carrier cells” did not incite
intrarenal injury in MRL-Fas lpr strains defi-
cient in TCR ab, CD4, or b2m. In the TCR ab-
deficient MRL-Fas lpr (B), CD4-deficient MRL-
Fas lpr (C) and b2m-deficient MRL-Faslpr strains
(D), GM-CSF “carrier cells” elicited fewer
kidney infiltrating cells than in the wild-type
strain. These are evaluated at 28-days postim-
plant (N 5 3 to 5 per group). Data are repre-
sentative of six separate experiments. sc, sub-
capsular space (hematoxylin eosin, 3200).
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Table 2. Retrovirally infected GM-CSF “carrier cells” implanted lind Russell Center for Arthritis Research (D.W.). T.W. was a recipient
of a grant from the Japan Society for the Promotion of Science. A.S.under the renal capsule increase circulating GM-CSF in MRL mice
was supported by the German Ernst Jung-Foundation for Research
Serum (CFU) and Science. We thank Dr. Joseph E. Craft for a kind gift of TCR ab-
deficient MRL-Fas lpr mice.Pre-lx Post-lx (d)
Recipient
(strain) TEC 28 Reprint requests to Vicki Rubin Kelley, Ph.D., Harvard Institute of
Medicine, 77 Avenue Louis Pasteur, Boston, Massachusetts 02115, USA.MRL-Faslpr GM-CSF 060 (0)a 1561b (1)
E-mail: VKelley @rics.bwh.harvard.edu.Uninf. 060 (0) 060
TCRab-/-MRL-Faslpr GM-CSF 060 (0) 1062b (0)
CD4-/-MRL-Faslpr GM-CSF 060 (0) 962b (0)
APPENDIXUninf. 060 060 (0)
b2m-/-MRL-Faslpr GM-CSF 060 (0) 1261b (0) Abbreviations used in this article are: CFU, colony forming unit;Uninf. 060 (0) 060
CSF-1, colony stimulating factor-1; DEPC, diethylpyrocarbonate;
Recipient mice were 2–3 mo of age. N 5 3–4/group. Number of implanted DN T, double negative T-cells; GM-CSF, granulocyte-macrophage col-
cells, 1 3 106/mouse. GM-CSF was measured by colony stimulating assay as ony-stimulating factor; IFN-g, interferon gamma; MCP, monocyte
CFU per 105 bone marrow cells. chemoattractant protein; MRL-FAS lpr, Mf , macrophage; MRL/MPJ-
Positive standard for the assay is MRL-Faslpr sera at 6 months of age, 49 6 5 lpr/lpr mouse strain; TCR, T-cell receptor; TEC, tubular epithelialCFU. Abbreviations are: CFU, colony forming units; Ix, implantation; Uninf,
cells; TNF-a, tumor necrosis factor-a.retroviral uninfected TEC
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